Ann Li Lee
Direttore/Membro del Consiglio presso JW (CAYMAN) THERAPEUTICS CO. LTD
Posizioni attive di Ann Li Lee
Società | Posizione | Inizio | Fine |
---|---|---|---|
JW (CAYMAN) THERAPEUTICS CO. LTD | Direttore/Membro del Consiglio | 22/05/2020 | - |
Independent Dir/Board Member | 29/08/2023 | - | |
CELGENE | Corporate Officer/Principal | 01/03/2018 | - |
Storia della carriera di Ann Li Lee
Precedenti posizioni note di Ann Li Lee
Società | Posizione | Inizio | Fine |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2009 | - |
JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/11/2017 | - |
Formazione di Ann Li Lee
Yale University | Doctorate Degree |
Cornell University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Cina | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
Aziende private | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Ann Li Lee
- Esperienza